A eukaryotic growth medium (Program Development Research Group Basal Growth Medium) was developed for CO 2 -independent maintenance and propagation of human and nonhuman tumor cell lines representing diverse histologies (e.g., cancers of the brain, colon, lung, ovary, and kidney, as well as leukemia and melanoma). It was also shown to be suitable for the maintenance and propagation of nontumor cells of human and nonhuman derivation. The medium derives its buffering capacity primarily from B-glycerophosphate, exhibits a stable physiologic pH of 7.3-7.4, and is optimized to facilitate growth in atmospheric CO 2 . It is also useful in cellular growth and cytotoxicity assays based on either the metabolic reduction of tetrazolium reagents or protein staining. The 50% inhibitory concentration values obtained with car-
The disease-oriented, preclinical drug discovery strategy of the Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute, requires panels of human tumor cell lines for the initial in vitro screening of candidate agents (/) . Panels represent a broad range of neoplasia and currently include central nervous system, colon, lung, renal, and ovarian cancer cell lines, and melanoma and leukemia cell lines. The large scope (10,000 compounds/yr) of the drug screening effort results in considerable extension or variations, or both, in the time required for technicians to perform routine manipulations, such as subculturing of cells, seeding of assay plates^ drug treatment,. and determination of cell viability at the end of the incubation period. This necessitates removal of cells from the standard incubator environment containing 5% CO 2 , thereby resulting in relatively lengthy periods in which cells are exposed to atmospheric CO 2 (0.04%). These cells, in turn, are exposed to excessively alkaline pH, potentially leading to artifactual alterations in cellular growth characteristics, viability, or apparent drug sensitivity. In addition, alkalinization of RPMI-1640 resulted in erratic and unpredictable formation of extracellular crystals (2) when the 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H tetrazolium hydroxide (XTT) tetrazolium assay (3) was used for quantitation of cell viability following drug exposure.
In an attempt to obviate the above problems resulting principally from the increases in pH that occur when cell cultures are removed from the obligatory 5% CO 2 environment needed to maintain physiologic pH with a bicarbonate-based growth medium, we developed and evaluated an alternative CO 2 -independent medium for propagation of a broad range of human or nonhuman tumor cell lines as well as nontumor lines of human and nonhuman origin.
Materials and Methods

Comparative Buffering Capacity and pH Stability of Several Media
Fifteen milliliters of serum-free medium was adjusted to pH 6.0 with 1 NHC1. Sodium hydroxide (1 N) was added in 15-u,L aliquots, and the pH was determined after vigorous vortexing. We examined the pH stability of RPMI-1640 and Program Development Research Group (PDRG) Basal Growth Medium in atmospheric CO 2 in 96-well microtiter plates with 200 \iL of medium/well by measuring the change in pH over 30 minutes. 2 The following cell lines, obtained from the tumor repository (Frederick, MD), were used for studies designed to examine the feasibility of propagating human and nonhuman cells in atmospheric CO 2 
Adaption of Cell Lines to Growth in Atmospheric CO
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where Tu is the unit period (1 day), In is the natural logarithm, N 2 is the cell number on day (n + 1), N, is the cell number on day (n), and T obs is the observation period in days. Cell doubling times were calculated according to the equation: 2 The cytotoxic effects of doxorubicin, carmustine, and tamoxifen on selected human tumor cell lines was evaluated by the tetrazolium assay (5) and the SRB protein assay (6).
Results
Medium Formulation
The HT 29 colon adenocarcinoma line was used as a prototype for most studies designed to address several critical areas for optimization of the new medium for growth of cells in culture in atmospheric CO 2 . The formulation of PDRG Basal Growth Medium (table 1) is the result.
The elimination of the high bicarbonate concentration (25 mM) present in most commercial media used to grow eukaryotic cells necessitated selection of an alternative buffering system. The PDRG formulation consists of high concentrations of selected amino acids and, in this respect, is similar to the approach first described by Leibovitz (7) in the development of the L-15 medium. The PDRG formulation also incorporates high concentrations of the free bases of several L-amino acids: arginine, cysteine, histidine, lysine, and tyrosine. In addition, PDRG Basal Growth Medium is buffered by 20 mM B-glycerophosphate, an organic phosphate first described by Ling et al. (8) . It was further optimized for cell growth in atmospheric CO 2 by incorporation of biotin, low concentrations of bicarbonate ion, pyruvic acid, and asparagine. The requirement of bicarbonate ion for several biochemical processes including fatty acid biosynthesis (9) prompted its inclusion in the formulation of PDRG Basal Growth Medium at a concentration of 75 mg/L, which is in excess of that provided by serum. This was the maximum concentration of bicarbonate that could be added to the medium without requiring exogenous CO 2 buffering to maintain a stable pH.
Comparative Buffering Capacity and pH Stability
The base titration of an acidified aliquot (pH 6.0) of each culture medium provided a measure of relative buffering capacity HPW *630 PDPG BASAt GPOWTW M n«JW Figure 1 . Medium buffering capacity and pH stability in atmospheric CO 2 . Left (buffering capacity): Fifteen mL of serum-free RPMI-1630, L-15, and PDRG Basal Growth Medium was adjusted to pH 6.0 with I N HC1. Sodium hydroxide (I N) was added in 15-p.L aliquots, and the pH was determined. Right (pH stability): 96-well microtiter plates containing 200 |xL of either RPMI-1640 or PDRG Basal Growth Medium were allowed to equilibrate at 37 °C in a humidified 5% CO 2 environment (RPMI-1640) or in atmospheric CO 2 (PDRG Basal Growth Medium). Media were supplemented with 5% fetal calf serum. The pH of the medium in the wells was determined following exposure to atmospheric CO 2 for the indicated time.
( fig. 1) . Resistance of the PDRG medium to alkalinization was substantially greater than was that of either RPMI-1630 or L-15. The pH stability of PDRG medium in atmospheric CO 2 contrasts with the rapid alkalinization that occurs when 96-well microtiter plates containing RPMI-1640 are removed from the 5% CO 2 environment required to maintain a physiologic pH ( fig. 1) .
Adaptation of Human Tumor Cell
Lines to Growth in Atmospheric CO 2 Initial experiments were undertaken with the HT 29 colon adenocarcinoma cell line. Growth profiles in RPMI-1630, L-15, and PDRG Basal Growth Medium in atmospheric CO 2 were compared with those obtained with cells grown in RPMI-1640 under5%CO 2 . Theresults(datanot shown) indicated that removal of HT 29 from a 5% CO 2 environment and growth in atmospheric CO 2 in PDRG Basal Growth Medium was initially accompanied by a 50% reduction in cell growth. This was in contrast to 3.7-and 125-fold reductions in growth of HT 29 cells cultured in L-15 and RPMI-1630, respectively. Stable growth was obtained following three to four passages in the respective medium and resulted in nearly equivalent growth of the HT 29 cells in PDRG medium in atmospheric CO 2 and RPMI-1640 in 5% CO 2 . The results of similar adaptation experiments (data not shown) with other cell lines indicated that (a) RPMI-1630 was unsatisfactory for propagation of these cell lines in atmospheric CO 2 , (b) densities of cells grown in 5% CO 2 were higher than those obtained for cells grown in atmospheric CO 2 , and (c) PDRG Basal Growth Medium was superior to L-15 for growth of the K562 myelogenous leukemia, HT 29 colon adenocarcinoma, and the SN12KI renal carcinoma. Cell densities were equivalent in PDRG Basal Growth Medium and L-15 medium for the HOP 62 lung adenocarcinoma, the XF 498 glioblastoma, and the M19MEL melanoma. L-15 medium appeared to be superior to PDRG Basal Growth Medium for only OVCAR5. 2 Growth curves for selected human tumor cell lines in PDRG Basal Growth Medium and L-15 medium in atmospheric CO 2 and in RPMI-1640 in 5% CO 2 are presented in figure 2 . The doubling times (table 2) for the HOP 62 lung adenocarcinoma. the SN12K1 renal carcinoma, and the XF 498 glioblastoma were slightly longer in PDRG Basal Growth Medium in atmospheric CO 2 than in RPMI-1640 under 57c CO 2 . The greatest discrepancy, a 2.7-fold increase, was found for the OVCAR 5 ovarian carcinoma. In contrast, the doubling times for the M19MEL melanoma and the HT 29 colon adenocarcinoma were shorter in atmospheric CO 2 than in 5% CO 2 . 2 Adaptation of tumor cell lines representing central nervous system, colon, renal, lung, melanoma, and ovarian histologies to growth in atmospheric CO 2 in PDRG Basal Growth Medium was generally complete following two to three passages. This contrasted with results obtained with the K562 myelogenous leukemia line. Removal of K562 from RPMI-1640 and growth in PDRG Basal Growth Medium in atmospheric CO 2 was accompanied by a progressive decline in growth for three passages followed by five to six passages of generally stable growth. However, although growth of K562 in PDRG Basal Growth Medium was superior to that in L-15 or RPMI-1630 ( fig. 2) , it was substantially less than that in RPMI-1640 and 5% CO 2 ( fig. 2 ). These observations suggested that metabolic production of CO 2 for use in purine and pyrimidine biosynthesis (9) is a limiting factor. Supplementation of PDRG Basal Growth Medium with purine and pyrimidine bases or their ribonudeotides or deoxyribonucleotides resulted in minimal growth stimulation (data not shown). However, supplementation of PDRG Basal Growth Medium with the purine nucleosides adenosine. guanosine, and inosine; the pyrimidine nucleosides cytidine and uridine: and the pyrimidine precursor orotic acid (table I) resulted in the elimination of the lengthy adaptive period of K562 to growth in atmospheric CO 2 and considerable stimulation of growth of this cell line in atmospheric CO-, (fig. 2) . Growth rates of K562 in this "modified PDRG Basal Growth Medium in atmospheric CO-, and in RPMI-1640 and 5% CO 2 were similar (table 2).
Growth Curves of Cell Lines in Atmospheric CO
Optimization of PDRG Basal Growth Medium for Propagation of Leukemia Cells in Atmospheric CO
We used this modified PDRG Basal Growth Medium to evaluate the growth in atmospheric CO 2 of four human and one murine fibroblast as well as the murine P388 and LI210 lymphocytic leukemias. Growth curves of four human (data not shown for CCD 19LU and Mar Bel) and one murine fibroblast ( fig. 3 ) in 59c CO 2 and in atmospheric CO 2 were nearly identical: growth of the murine L1210 lymphocytic leukemia in 5% and atmospheric CO 2 was also identical (fig. 3) . whereas growth of the murine P388 lymphocytic leukemia was slightly less in atmospheric CO, (data not shown). * Doubling times were calculated from the day 2 cell counts presented in fig. 2 according to the method of Skehan (4) .
tPDRG Basal Growth Medium was supplemented with 10 mg each of adenosine, cytidine, guanosine, and uridine/L; 25 mg of inosine/L; and 15 mg of orotic acid/L.
Fifty Percent Inhibitory Concentration (IC S0 ) Values for Selected Drugs
The IC 50 values obtained for doxorubicin, carmustine, and tamoxifen on cells maintained in PDRG medium under atmospheric CO 2 and on cells in RPMI-1640 under 5% CO 2 are presented in table 3. Values obtained under both experimental conditions were closely comparable. However, in general, the apparent cell sensitivity was greater with the MTT-tetrazolium assay, compared with the SRB protein assay. 
Discussion
The results described here indicate that a broad range of human and nonhuman and tumor and nontumor cell lines representing various major histologic types can be successfully adapted to growth in atmospheric CO 2 in PDRG Basal Growth Medium (table 1) . The optimal growth environment for cells in the medium does not require exogenous CO 2 , because bicarbonate ion is eliminated as the primary buffering component. The rationale for including bicarbonate ion in the formulation of PDRG Basal Growth Medium at a reduced concentration is based on results of several earlier investigations that demonstrated growth promotion by bicarbonate of several cell lines in vitro (10-16) . The requirement of CO 2 for a variety of cellular biochemical processes, including biosynthesis of purines, pyrimidines, and fatty acids (9,17,18) resulted in incorporation in the growth medium of several components designed to facilitate metabolic production and utilization of CO 2 : biotin, a cofactor for carboxylation reactions; pyruvic acid, a monocarboxylic acid that acts as a metabolic source of CO 2 via decarboxylation and as a provider of acetyl coenzyme A for metabolic stimulation of CO 2 production by the tricarboxylic acid cycle; and L-asparagine, a C 4 amino acid that can be converted intracellularly to L-aspartic acid and oxaloacetic acid by the cytosolic enzyme L-asparagine amidohydrolase (E.C. 3.5.1.1.) and the mitochondrial enzyme L-aspartate 2-oxoglutarate aminotransferase (E.C. 2.6.1.1.), respectively (9) . In addition, oxaloacetic acid, a tricarboxylic acid cycle intermediate, was evaluated by Runyan and Geyer (19) as a partial replacement for CO 2 . We found that oxaloacetic acid increased cell proliferation in several cell lines but was not included in the PDRG Basal Medium formulation because it produced marked inhibition of cell growth in the OVCAR 5 ovarian carcinoma, the XF 498 glioblastoma, and the K562 myelogenous leukemia (data not shown). Additionally, oxaloacetic acid undergoes spontaneous decarboxylation that results in alkalinization of growth medium (19) .
In the present study, we observed that the buffering capacity of both L-15 and RPMI-1630 was substantially less than that observed for PDRG Basal Growth Medium ( fig. 1) . The pH titration curve of Table 3 . IC50 values for doxorubicin, tamoxifen, and carmustine in 5% and atmospheric CO2 determined by either the MTT or SRB assays* Drug Doxorubicin Tamoxifen   Carmustine   Cell line   M19MEL  A2780  M19MEL  A2780  XF498  SN12KI  M19MEL  A2780  XF498  SN12KI   IC L-15 indicated that the optimal buffering pH range of L-15 is 7.8 to 8.5, an observation that could most likely be attributed to the presence of high concentrations of the free bases of L-arginine, -cysteine, -histidine, -lysine, and -tyrosine. A reduction in the concentrations of these amino acids in the formulation of PDRG Basal Growth Medium, as well as the inclusion of 20 mM B-glycerophosphate (pK a = 6.6), resulted in both a shift in the optimum buffering range toward physiologic pH and an increased buffering capacity, compared with L-15 and RPMI-1630 ( fig.  1) . RPMI-1630, of which dibasic sodium phosphate is the primary buffer (20) , was unsatisfactory for propagation of a broad range of cells in atmospheric CO 2 .
L-15, developed by Leibovitz for propagation of cells in atmospheric CO 2 (7) was superior to RPMI-1630 in the current study ( fig. 2 ), but it is unsatisfactory in metabolic assays that require measurement of cellular viability with tetrazolium salts (2); this has been attributed to the substitution of D-galactose for D-glucose in the formulation of L-15. The use of Dgalactose may result in reduced cellular concentrations of NADH and NADPH that are principally generated by the metabolism of glucose (9) ; the reduced pyridine nucleotides are cofactors used for the enzymatic reduction of the tetrazolium salts (21).
A common practice among investigators to reduce alkalinization of medium, which occurs when bicarbonate-based culture medium is removed from a CO 2 environment, is to supplement the medium with HEPES. Prior to the development of PDRG Basal Growth Medium, we determined that inclusion of HEPES in RPMI-1640 resulted in toxic effects to several cell lines and that erratic dose-response curves resulted when the MTT tetrazolium assay was used to measure cellular viability. Other investigators established that exposure of tissue culture media to visible light results in the formation of toxic products that cause cessation of growth (22) , cell death (23) , and chromosome abnormalities (24) . Several studies (25, 26) have confirmed the original observation of Warburg et al. (23) that phototoxic effects are attributable to the presence of riboflavin and the aromatic amino acids tyrosine and tryptophan. Wang and Nixon (27) made the original observations that phototoxicity was attributable to hydrogen peroxide production. Phototoxicityofriboflavin is accentuated in HEPES-containing growth medium (28) , and a recent study demonstrated that exposure of RPMI-1640 containing HEPES to visible light for 30 minutes resulted in production of hydrogen peroxide, inhibition of thymidine uptake, and cell death (29) .
PDRG Basal Growth Medium exhibits several desirable characteristics for use in a high-flux antitumor drug screening application. First, the medium has good pH stability and buffering capacity in atmospheric CO 2 , a quality that prevents changes in medium pH during periods when cells are being seeded into assay plates and during drug treatment. Second, the medium exhibits the capability for large-scale growth of a broad range of human tumor cell lines. Third, because D-glucose is the principal carbohydrate in the formulation, the medium is compatible for use with either tetrazolium-or proteinbased assays for the determination of cellular viability.
Incorporation of nucleic acid derivatives (purine or pyrimidine precursors and nucleosides) would be expected to reduce the cytostatic and cytotoxic potency of some antimetabolites such as methotrexate (30) and fluorouracil (31). Recent experiments in this laboratory indicate that cells growing in PDRG Basal Growth Medium supplemented with adenosine, cytidine, guanosine, inosine, orotic acid, and uridine are more resistant to methotrexate than are cells grown in RPMI-1640 (data not shown).
Although the new cell culture medium described herein was developed initially to solve problems encountered in a high-flux antitumor drug screening application, the resulting product may have broader applications. The new medium may be valuable for general use in cell culture research and development, as well as in specialized cell culture technologies, such as mass production of cells or their products (e.g., growth factors, hormones, etc.), with hollowfiber methods or other procedures when the use of CO 2 for control of medium pH is cumbersome and expensive.
